alpha Enolase Antibody (28): sc-101515

α Enolase Antibody (28) is a mouse monoclonal IgG1 antibody that detects α enolase in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). α enolase (28) antibody recognizes a crucial enzyme in the glycolytic pathway, facilitating the conversion of 2-phosphoglycerate to phosphoenolpyruvate, a key step in energy production. Anti-α enolase antibody (28) targets a protein vital for cellular metabolism and various physiological processes, including differentiation and cellular signaling. α enolase expression spans multiple tissues, appearing in a wide range of cells, including those in the brain, muscle, and other organs. Post-translational modifications, such as phosphorylation, can influence α enolase activity and interactions with other proteins, thereby affecting metabolic regulation and cellular responses. α enolase monoclonal antibody (28) detects a protein that can form both homodimers and heterodimers with other enolase isoforms, adding another layer of complexity to its function, making α enolase a critical target for research in metabolic diseases and cancer. With broad species reactivity and versatile applications, anti-α enolase antibody (28) serves as an essential tool for researchers studying glycolysis and its implications in health and disease.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

alpha Enolase Antibody (28) References:

1. α-Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps.  |  Mori, Y., et al. 2012. J Biol Chem. 287: 10472-10481. PMID: 22262863
2. Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.  |  Nezos, A., et al. 2017. Clin Immunol. 183: 300-303. PMID: 28919520
3. Alpha-enolase staining patterns in the renal tissues of cats with and without chronic kidney disease.  |  McLeland, S., et al. 2019. Vet Immunol Immunopathol. 212: 23-26. PMID: 31213248
4. Evaluation of systemic lupus erythematosus disease activity using anti-α-enolase antibody and RDW.  |  Huang, Y., et al. 2021. Clin Exp Med. 21: 73-78. PMID: 32857322
5. Evaluation of autoantibodies against vimentin and α-enolase in rheumatoid arthritis patients.  |  Ebrahimi-Rad, M., et al. 2020. Reumatologia. 58: 350-356. PMID: 33456077
6. Molecular docking of alpha-enolase to elucidate the promising candidates against Streptococcus pneumoniae infection.  |  Hassan, M., et al. 2021. Daru. 29: 73-84. PMID: 33537864
7. Amoxicillin Haptenation of α-Enolase is Modulated by Active Site Occupancy and Acetylation.  |  González-Morena, JM., et al. 2021. Front Pharmacol. 12: 807742. PMID: 35095517
8. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation.  |  Inoue, Y., et al. 2022. Cell Mol Life Sci. 79: 462. PMID: 35916996
9. Generation and characterization of avian single chain variable fragment against human Alpha-Enolase.  |  Lee, CH., et al. 2023. Int Immunopharmacol. 120: 110277. PMID: 37196558
10. Anti-citrullinated α-enolase peptide as a highly sensitive autoantigen in patients with rheumatoid arthritis.  |  Yeh, FC., et al. 2023. Heliyon. 9: e22745. PMID: 38089987

The preferred α Enolase antibody is α Enolase Antibody (L-27): sc-100812.